{
    "Trade/Device Name(s)": [
        "Cito CBC System"
    ],
    "Submitter Information": "CytoChip Inc.",
    "510(k) Number": "K240402",
    "Predicate Device Reference 510(k) Number(s)": [
        "K112605"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GKZ"
    ],
    "Summary Letter Date": "February 3, 2025",
    "Summary Letter Received Date": "February 9, 2024",
    "Submission Date": "February 9, 2024",
    "Regulation Number(s)": [
        "21 CFR 864.5220"
    ],
    "Regulation Name(s)": [
        "Automated Differential Cell Counter"
    ],
    "Analyte Class(es)": [
        "hematology"
    ],
    "Analyte(s)": [
        "White blood cell count",
        "Red blood cell count",
        "Platelet count",
        "Hemoglobin concentration",
        "Hematocrit",
        "Mean corpuscular volume",
        "Neutrophil count",
        "Neutrophil percentage",
        "Lymphocyte count",
        "Lymphocyte percentage",
        "Monocyte count",
        "Monocyte percentage",
        "Eosinophil count",
        "Eosinophil percentage",
        "Basophil count",
        "Basophil percentage"
    ],
    "Specimen Type(s)": [
        "Whole blood"
    ],
    "Specimen Container(s)": [
        "K2EDTA vacutainer tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Cito CBC Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Fluorescent flow cytometry",
        "Photometry"
    ],
    "Methodologies": [
        "Flow cytometry",
        "Photometric measurement"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Cartridge",
        "Kit",
        "Reagent",
        "Consumable",
        "Software"
    ],
    "Document Summary": "FDA 510(k) summary for Cito CBC System, an automated hematology analyzer using flow cytometry and photometry for quantitative CBC and 5-part differential counts in venous K2EDTA whole blood.",
    "Indications for Use Summary": "Intended for in vitro diagnostic quantitation of CBC and 5-part WBC differential parameters from venous whole blood anticoagulated with K2EDTA; not for use in oncology or critically ill patients, or children under 2 years.",
    "fda_folder": "Hematology"
}